Skip to content

MONO-VIDITEST anti-HHV-6 IgM

by VIDIA spol. s r.o. 2 variants

Ref KZ-161-12Model MONO-VIDITEST anti-HHV-6 IgM

Active European Union

CE IVDD

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 25 Oct 2026. What this means

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-38594036041616 Basic UDI-DI 38594036041616UDI-DIDate10 Jun 2026RegisteredStatusActive

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Model / Reference
MONO-VIDITEST anti-HHV-6 IgM, KZ-161-12
Primary DI / UDI-DI
38594036041616
Basic UDI-DI
B-38594036041616
EMDN Code
W0105040524 Hhv-6,7,8 - na reagents
Device Class
Class IVD General
EU market of registration
Czechia

Manufacturer details

EUDAMED SRN
CZ-MF-000036964

Other devices from VIDIA spol. s r.o.

See all devices from VIDIA spol. s r.o. →

Properties

  • Human Tissues
  • Microbial Substances
  • Professional Testing

Other properties (7)

  • Sterile: No
  • Animal Tissues: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No